Accrued liabilities consisted of the following (in thousands):
March 31, 2026
December 31, 2025
Research and development costs
$
4,502
4,700
Compensation-related expenses
1,518
2,913
Other
755
422
Total accrued liabilities
6,775
8,035
No definition available.
Tabular disclosure of the components of accrued liabilities.